Table 6.
Comparison of Laboratory Parameters Between the Survivor and Non-Survivor of COVID-19 Patients without Underlying Diseases
| Survivor | Non-Survivor | P value | |
|---|---|---|---|
| WBC, ×109/L | 4.6 (3.6–5.8) | 12.6 (5.5–17.9) | <0.001 |
| Lymphocytes, ×109/L | 1.2 (0.9–1.7) | 0.6 (0.4–0.7) | <0.001 |
| Neutrophils, ×109/L | 2.9 (2.1–3.6) | 11.4 (4.7–17.0) | <0.001 |
| CRP, mg/L | 12.7 (4.0–27.9) | 70.1 (29.6–254.3) | <0.001 |
| TC/HDL-c ratio | 4.5 (3.7–5.6) | 4.9 (3.3–5.5) | 0.899 |
| LDL-c/HDL-c ratio | 3.2 (2.5–4.1) | 2.2 (1.5–3.5) | 0.010 |
| TG/HDL-c ratio | 1.3 (0.9–2.0) | 1.9 (1.6–8.4) | 0.001 |
Notes: P values indicate differences between survivor and non-survivor of COVID-19 patients without underlying diseases. P<0.05 was considered statistically significant (marked in bold).
Abbreviations: COVID-19, Coronavirus disease 2019; WBC, White blood cells; CRP, C-reactive proteins; TC/HDL-c ratio, total cholesterol-to-high-density lipoprotein cholesterol ratio; LDL-c/HDL-c ratio, low-density lipoprotein cholesterol-to-high-density lipoprotein cholesterol ratio; TG/HDL-c ratio, triglyceride-to-high-density lipoprotein cholesterol ratio.